Buy This 1 Cannabis Stock for Longer-Term Growth Potential

Tilray (NASDAQ:TLRY) could be the right stock at the right time. But is it too expensive for casual investors right now?

| More on:
edit Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

There wasn’t much of a Santa Claus Rally. But considering the holiday period just past, perhaps that’s not much of a shock. The bullishness that characterized much of the latter half of the Year That Shall Not Be Named had largely leached out of the markets come December. There was still a fair amount of green ink in the markets at the end of the year. But this week has seen a lot of red ink taking its place.

Weighing price with growth potential

January is often a good time to pick up a bargain. 2021 is already proving that this year is no exception. A lot of quality names are on sale. For cannabis investors still hemming and hawing over the merger of Tilray (NASDAQ:TLRY) and Aphria (TSX:APHA)(NASDAQ:APHA), a potential pullback in share prices could offer a buying opportunity to scoop up some knocked-down stock.

Tilray investors have been keen on the news. The marijuana product developer’s stock jumped 22.8% as the potential acquisition made waves in the investment community. The gains fell away by the end of that week, though, to close up 1.2% just two days later. Aphria closed out that week up 2.6%. This month sees Tilray up 9.8%, and Aphria up 2.9%. But in the already volatile January market, a retreat could be imminent.

A future wide-moat cannabis stock?

Cannabis still has a long way to go before it’s a trusted asset. It’s certainly not the kind of commodity that can be packed with confidence into a lower risk portfolio. Consider, for example, a Tax-Free Savings Acount (TFSA) founded on such asset classes as chemicals and metals. What would it take for marijuana to be included on this list? For the general investor who is still dubious about cannabis growth potential, the challenges might always remain insurmountable.

But in years to come, such names as Tilray could come to command positions of wide-moat authority. This would take a period of high-level M&A. But that period has now been kick-started. Whether Tilray will be one of the eventual market leaders is of course up to history to decide. For now, though, Tilray could be a tentative buy for speculative investors going long on the green stuff.

Now, Tilray may be hot of late, but investors may want to treat this name with caution. Its 36-month beta is way up at 3.17. Consider, for a moment, the volatility of the market in the last three years. This stock is more than three times as frothy – and much of that froth has been churned up in the last 12 months alone. In just the last three months, Tilray has gained 70%.

In summary, Tilray is worth buying for a number of reasons. But because this is still a highly speculative market, Tilray may need to come down in price. Yes, there’s that 42% 12-month overall decline. But this stock still trades with a P/B ratio of 6.1. Considering that pot stocks can sell at their book price right now, Tilray may still be too rich for some investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned.

More on Cannabis Stocks

Upwards momentum
Energy Stocks

3 Canadian Stocks That Could be Huge Winners in the Next Decade and Beyond

Stocks like Canopy Growth, Blackberry, and Ballard Power are leading and redefining new multi-billion dollar industries.

Read more »

A cannabis plant grows.
Cannabis Stocks

Should You Invest in Canadian Cannabis Stocks Like Canopy Growth in September?

Canadian cannabis stocks, including Canopy Growth, remain high-risk bets for investors, despite trading 94% below all-time highs.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

ACB Stock: What’s Behind Aurora Cannabis’ Recent Surge?

More countries are legalizing marijuana. Should you buy ACB stock?

Read more »

data analytics, chart and graph icons with female hands typing on laptop in background
Cannabis Stocks

Got $5,000? 3 Stocks to Hold for the Next 20 Years

Long-term investors can consider buying shares of Dollarama and Curaleaf to generate market-beating gains in the next two decades.

Read more »

A cannabis plant grows.
Cannabis Stocks

Is Now the Time to Buy Cannabis Stocks?

These cannabis stocks are up 70% and 19% this month! Should Canadian investors hop on board?

Read more »

A cannabis plant grows.
Cannabis Stocks

Why I’m Considering Canopy Growth Stock For My RRSP

As the cannabis industry grows, adding Canopy Growth stock to my RRSP will give me access to massive upside.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock Jumps 20%: Here’s What Happened

Canopy Growth stock (TSX:WEED)(NASDAQ:CGC) popped 20% on Monday from an announcement made by another cannabis producer.

Read more »

Retirement plan
Dividend Stocks

4 Stocks That Could Turn $100,000 Into $500,000 by the Time You Retire

Companies such as Brookfield Asset Management have the potential to consistently beat the broader markets and deliver stellar returns to…

Read more »